Anticancer effects of baicalein on hepatocellular carcinoma cells

Phytotherapy Research

Volumn 28, Issue 9, 2014, Pages 1342-1348

  Zheng, Yi Hu ^a   Yin, Li Hui ^a   Grahn, Tan Hooi Min ^b   Ye, Ai Fang ^a   Zhao, Yan Rong ^a   Zhang, Qi Yu ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Baicalein; Hepatocellular carcinoma; catenin

Indexed keywords

BAICALEIN; BETA CATENIN; CYCLIN D1; CYCLOPHOSPHAMIDE; GLYCOGEN SYNTHASE KINASE 3BETA; PROTEIN KINASE B; CCND1 PROTEIN, HUMAN; CTNNB1 PROTEIN, HUMAN; FLAVANONE DERIVATIVE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER INHIBITION; CELL CYCLE CHECKPOINT; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DRUG MECHANISM; ENZYME INHIBITION; EX VIVO STUDY; G0/G1CELL CYCLE ARREST; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; LIVER WEIGHT; MALE; MOUSE; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SPLEEN WEIGHT; TRANSCRIPTION REGULATION; TUMOR XENOGRAFT; ANIMAL; CELL PROLIFERATION; DRUG EFFECT; DRUG SCREENING; INSTITUTE FOR CANCER RESEARCH MOUSE; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE; Β-CATENIN;

BAICALEIN; HEPATOCELLULAR CARCINOMA; Β-CATENIN;

ANIMALS; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; FLAVANONES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LIVER NEOPLASMS; MALE; MICE, INBRED ICR; PROTO-ONCOGENE PROTEINS C-AKT; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84907933131     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.5135     Document Type: Article

References (19)

1. Abdel aziz MT, El Asmar MF, Atta HM, et al. 2011. Efficacy of mesenchymal stem cells in suppression of hepatocarcinorigenesis in rats: possible role of Wnt signaling. J Exp Clin Cancer Res 30: 49.
2. Chao JI, Su WC, Liu HF. 2007. Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT. Mol Cancer Ther 6 : 3039-3048.
3. Cheng YH, Li LA, Lin P, et al. 2012. Baicalein induces G1 arrest in oral cancer cells by enhancing the degradation of Cyclin D1 and activating AhR to decrease Rb phosphorylation. Toxicol Appl Pharmacol 263: 360-367.
4. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378: 785-789.
5. Hui C, Qi X, Qianyong Z, Xiaoli P, Jundong Z, Mantian M. 2013. Flavonoids, flavonoid subclasses and breast cancer risk: a meta-analysis of epidemiologic studies. PLoS One 8: e54318.
6. Ishiki N, Onishi H, Machida Y. 2004. Evaluation of antitumor and toxic side effects of mitomycin C-estradiol conjugates. Int J Pharm 279: 81-93.
7. Jiang L, Yu K, Du J, et al. 2011. Inhibition of p38 MAPK activity in B-NHL Raji cells by treatment with engineered CD20-specific T cells. Oncol Lett 2: 753-758.
8. Lencioni R, Chen XP, Dagher L, Venook AP. 2010. Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved? Oncologist 15(Suppl 4): 42-52.
9. Li-Weber M. 2009. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents Wogonin, Baicalein and Baicalin. Cancer Treat Rev 35: 57-68.
10. Miyoshi Y, Iwao K, Nagasawa Y, et al. 1998. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58: 2524-2527.
11. Mulcahy MF, Wahl AO, Small W, Jr. 2005. The current status of combined radiotherapy and chemotherapy for locally advanced or resected pancreas cancer. J Natl Compr Canc Netw 3: 637-642.
12. Park S, Gwak J, Cho M, et al. 2006. Hexachlorophene inhibits Wnt/beta-catenin pathway by promoting Siah-mediated beta-catenin degradation. Mol Pharmacol 70: 960-966.
13. Polakis P. 2002. Casein kinase 1: a Wnt'er of disconnect. Curr Biol 12: R499-R501.
14. Srivastava AK, Pandey SK. 1998. Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol Cell Biochem 182: 135-141.
15. Tayarani-Najaran Z, Emami SA, Asili J, Mirzaei A, Mousavi SH. 2011. Analyzing cytotoxic and apoptogenic properties of Scutellaria litwinowii root extract on cancer cell lines. Evid Based Complement Alternat Med 2011: 160682.
16. Venook AP, Papandreou C, Furuse J, de Guevara LL. 2010. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15 (Suppl 4): 5-13.
17. Wang L, Lee IM, Zhang SM, Blumberg JB, Buring JE, Sesso HD. 2009. Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am J Clin Nutr 89: 905-912.
18. Whittaker S, Marais R, Zhu AX. 2010. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene 29: 4989-5005.
19. Wong CM, Fan ST, Ng IO. 2001. beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer 92: 136-145.